ApolloBio

Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize DNA Immunotherapy product (VGX-3100) in Greater China
CP Wire
Tue, 03/20/18 - 03:34 pm
Inovio
China
ApolloBio
VGX-3100
DNAi-based therapeutics
HPV
Inovio lands $23m in collab with ApolloBio for HPV immunotherapy
Drug Delivery Business News
Tue, 01/2/18 - 11:39 am
Inovio
ApolloBio
HPV
immunotherapy